A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Clinical trial NCT06673368 · TERMINATED
Trial details
- NCT number
- NCT06673368
- Sponsor
- Neurocentria, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2025-07-15
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.